Osiris Therapeutics
Signal active
Organization
Contact Information
Overview
Osiris Therapeutics, Inc. is a stem cell company, which focuses on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular, orthopedic and wound healing markets. The company operates its business through two segments: Therapeutics and Biosurgery segment. The Therapeutics segment focuses on developing biologic stem cell drug candidates from readily available and non-controversial sources.
About
Industries
Biotechnology, Marketing, Medical Device
Founded
1992
Employees
501-1000
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Osiris Therapeutics headquartered in United States, North America, operates in the Biotechnology, Marketing, Medical Device sector. The company focuses on Biotechnology and has secured $4.6B in funding across 48 round(s). With a team of 501-1000 employees, Osiris Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Post-IPO Equity - Osiris Therapeutics, raised $15.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
1
Lead Investors
0
Total Funding Amount
$95.0M
Details
1
Osiris Therapeutics has raised a total of $95.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2005 | Private Equity | 50.0M |
Investors
Osiris Therapeutics is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Osiris Therapeutics | - | FUNDING ROUND - Osiris Therapeutics | 30.0M |
| Friedli Corporate Finance | - | FUNDING ROUND - Friedli Corporate Finance | 30.0M |
| Osiris Therapeutics | - | FUNDING ROUND - Osiris Therapeutics | 15.0M |
| Mesoblast | - | FUNDING ROUND - Mesoblast | 15.0M |
Recent Activity
There is no recent news or activity for this profile.